Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure INTERNATIONAL JOURNAL OF HEMATOLOGY Sasaki, K., Yamashita, K., Miyoshi, T., Furukawa, Y., Kimura, T., Kita, T., Ichinohe, T., Ishikawa, T., Sasada, M., Uchiyama, T. 2007; 86 (1): 72-76


Angiogenesis is believed to be involved in the pathogenesis and progression of multiple myeloma (MM). In some young patients, the MM has been reported to be complicated with high-output cardiac failure (HOCF), in which an increase in the vascular bed may be involved in the pathogenesis; however, no throughput studies have been conducted to determine what angiogenic factors are associated with HOCF in MM patients. We experienced a 34-year-old MM patient with HOCF and used the cytokine array system to investigate the expression of angiogenic cytokines and related factors in his serum before and after treatment and to compare the results with those of a healthy volunteer. We treated the patient with chemotherapy in combination with autologous peripheral blood stem cell transplantation. Following the treatment, he showed a good partial response without any signs of cardiac failure. The patient had experienced dramatic increases in the expression levels of angiopoietin 2, insulin-like growth factor-binding protein 6, and glial cell line-derived neurotrophic factor. After treatment, the levels of these factors decreased remarkably in association with an improvement in the patient's clinical condition. We review previous case reports in our discussion of the significance of these findings in the pathogenesis of MM with HOCF.

View details for DOI 10.1532/IJH97.06226

View details for Web of Science ID 000249508100014

View details for PubMedID 17675271